These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1873425

  • 1. [Successful treatment of the neuroleptic malignant syndrome using i.v. dantrolene sodium in the neurologic intensive care station].
    Rechlin T, Hilz MJ, Claus D.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 May; 26(3):156-60. PubMed ID: 1873425
    [Abstract] [Full Text] [Related]

  • 2. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
    Khan A, Jaffe JH, Nelson WH, Morrison B.
    J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961
    [Abstract] [Full Text] [Related]

  • 3. The treatment of neuroleptic malignant syndrome using dantrolene sodium.
    Tsutsumi Y, Yamamoto K, Matsuura S, Hata S, Sakai M, Shirakura K.
    Psychiatry Clin Neurosci; 1998 Aug; 52(4):433-8. PubMed ID: 9766694
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome.
    Nisijima K, Noguti M, Ishiguro T.
    Biol Psychiatry; 1997 Apr 15; 41(8):913-4. PubMed ID: 9099421
    [No Abstract] [Full Text] [Related]

  • 6. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
    Schulte-Sasse U, Komar K, Eberlein HJ.
    Dtsch Med Wochenschr; 1985 Mar 22; 110(12):457-61. PubMed ID: 3979279
    [Abstract] [Full Text] [Related]

  • 7. [Neuroleptic malignant syndrome].
    Murak E.
    Psychiatr Pol; 1995 Mar 22; 29(3):349-58. PubMed ID: 7652088
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM, Shifrar KA.
    Clin Pharm; 1988 Sep 22; 7(9):697-701. PubMed ID: 3240662
    [Abstract] [Full Text] [Related]

  • 11. The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?
    Rosebush PI, Stewart T, Mazurek MF.
    Br J Psychiatry; 1991 Nov 22; 159():709-12. PubMed ID: 1843801
    [Abstract] [Full Text] [Related]

  • 12. Survival of severe neuroleptic malignant syndrome in a 78-year-old man treated with dantrolene.
    Kimerer NB, Parker DM, Sholer CM, Trammell JR.
    J Okla State Med Assoc; 1990 Mar 22; 83(3):122-4. PubMed ID: 2319382
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapy of neuroleptic malignant syndrome.
    Lazarus A.
    Psychiatr Dev; 1986 Mar 22; 4(1):19-30. PubMed ID: 3703852
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Emergency treatment of the neuroleptic malignant syndrome.
    Andrade NN.
    Hawaii Med J; 1988 Apr 22; 47(4):181-2, 185. PubMed ID: 3384642
    [No Abstract] [Full Text] [Related]

  • 17. Neuroleptic malignant syndrome.
    Haisma HJ, Constantinou E, Chinyanga HM.
    Cent Afr J Med; 1990 May 22; 36(5):141-3. PubMed ID: 2261628
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.